Phoenix Venture Partners, a San Mateo, Calif.-based venture capital firm focused on Advanced Materials, closed its new fund.
Limited partners in PVP II include financial institutions, family offices, and multinational corporations such as Pfizer Inc., 3M, Corning Incorporated (NYSE: GLW), Eastman Chemical Company (NYSE: EMN), Solvay Group S.A., Showa Denko K. K. (TSE:4004), and W. L. Gore & Associates.
The fund will focus exclusively on investing in startups developing Advanced Materials innovations. As in its prior fund PVP I LP, PVP II will work with a limited number of corporations from different value chain positions, geographies, and industries to identify industrial opportunities and to vet technologies. Partners also work with entrepreneurs, leveraging their domain experience as inventors, founders, startup operators, and C-level executives.
Led by Managing General Partners Dr. John T. Chen and Dr. Zachariah Jonasson, PVP also has a satellite office in Seattle, WA.